For example, discussion of a marital disagreement produced clinically significant increases in blood pressure
in patients with hypertension, with subjects reaching a mean of 160/100 mm Hg.
Conversely, the antioxidant lowers blood pressure
in patients with hypertension.
They found that,
in patients with hypertension, the total IgG serum level was independently associated with risk of coronary heart disease events.
Renal outcomes with different fixed - dose combination therapies
in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomized controlled trial.
In 2014, he and his colleagues discovered that these molecules are unusually abundant in certain immune cells of mice with high blood pressure — and that the same is true
in patients with hypertension.
«Vitamin D supplementation does not appear to reduce blood pressure
in patients with hypertension.»
Not exact matches
Mannkind, which focuses on the development and commercialization of inhaled therapeutic products for
patients with diseases such as diabetes and pulmonary arterial
hypertension, entered a shallow but persistent downtrend
in 2004, posting a series of lower highs into 2015.
van Bommel E, Cleophas T. Potassium treatment for
hypertension in patients with high salt intake: a meta - analysis.
As for the rest of the unpronounceable ingredients if you'd like to be nauseous, have irritated skin, or consume a chemical listed
with «use caution
in patients with cardiac failure,
hypertension, impaired renal function, peripheral and pulmonary edema, and toxemia of pregnancy» then just go ahead and grab that iced coffee from McDonald's to go (just incase you have to shit, puke, or have a heart attack).
The first phase of the trial was conducted
in 1998 - 2002 and included 10,180
patients aged 40 - 79
with hypertension and at least three other cardiovascular risk factors from the UK, Ireland and Scandinavia.
Patients showing gadolinium
in the vitreous chamber at the later timepoint tended to be of older age, have a history of
hypertension, and have more bright spots on their brain scans, called white matter hyperintensities, that are associated
with brain aging and decreased cognitive function.
Ophthalmologists at 10 sites nationwide tested the ring
in a phase 2 clinical trial on
patients with glaucoma or ocular
hypertension.
Among
patients with hypertension at high risk of cardiovascular disease, a program that consisted of
patients measuring their blood pressure and adjusting their antihypertensive medication accordingly resulted
in lower systolic blood pressure at 12 months compared to
patients who received usual care, according to a study
in the August 27 issue of JAMA.
In a separate analysis, the researchers examined the association of fruit consumption with total mortality and CV mortality in more than 61,000 patients from the China Kadoorie Biobank who had CVD or hypertension at baselin
In a separate analysis, the researchers examined the association of fruit consumption
with total mortality and CV mortality
in more than 61,000 patients from the China Kadoorie Biobank who had CVD or hypertension at baselin
in more than 61,000
patients from the China Kadoorie Biobank who had CVD or
hypertension at baseline.
A total of 159
patients (average age 77 years)
with isolated systolic
hypertension participated
in the randomized clinical trial.
Ibuprofen is associated
with increased blood pressure and
hypertension compared to celecoxib
in patients with osteoarthritis or rheumatoid arthritis and increased risk of cardiovascular disease, according to late - breaking results from the PRECISION - ABPM study presented today
in a Hot Line Session at ESC Congress1 and published
in EHJ.
Maintaining or achieving blood pressure control
in patients with arthritis and concomitant
hypertension (treated or untreated) could avoid more than 70,000 deaths from stroke and 60,000 deaths from coronary heart disease each year, 2 making it important to investigate the effects of various NSAIDs on blood pressure.
The study, which is published today
in the Journal of Clinical
Hypertension and is supported by Barts Charity, devised a novel treatment strategy for 55
patients, involving fractional dosing
with tablets (halving or quartering pills), liquid formulations of antihypertensive drugs and patch formulations of antihypertensive drugs — plus use of unlicensed drugs that lower blood pressure.
«Once we've shown that this can safely be used
in human
patients with pulmonary
hypertension — and we've got a clinical trial
in progress right now — we'll be able to conduct studies of inhaled NO delivered
in ambulatory settings, including
patients» homes, to treat chronic pulmonary
hypertension, right - sided heart failure and chronic obstructive pulmonary disease.»
Approximately 4
in 10 deaths associated
with pulmonary
hypertension occur among
patients under 75 years old.
Their findings, reported
in Nature Communications, may shed light on human lung disease,
in particular, the mechanism behind non-familial pulmonary
hypertension in patients with conditions such as emphysema and pulmonary fibrosis.
Mads E. Jørgensen, M.B., of Gentofte Hospital, University of Copenhagen, Denmark and coauthors examined
in - hospital records and out - of - hospital pharmacotherapy use
in Danish
patients with uncomplicated
hypertension treated
with at least two antihypertensive drugs (β - blockers, thiazides, calcium antagonists or renin - angiotensin system [RAS] inhibitors) undergoing noncardiac surgery between 2005 and 2011.
The results support current clinical guidelines on the treatment of
hypertension in younger
patients with CKD, but a more cautious blood pressure - lowering strategy for very elderly
patients with CKD may be reasonable.
Hypertension is the most important treatable risk factor for cardiovascular disease, and while it is especially common
in the elderly and
in patients with chronic kidney disease (CKD), these are the least studied groups
in randomized controlled trials examining the health effects of lowering blood pressure.
«Because PGAs are a first line of treatment for glaucoma, these results provide physicians
with one reason to reconsider when they should be added
in new
patients, particularly those where the aim is to prevent glaucoma such as
in ocular
hypertension patients or glaucoma suspects,» Dr. Pasquale said.
The findings showed that
in comparison to those
with systolic heart failure, diastolic heart failure
patients were older, more likely to be overweight, female and have
hypertension.
«Our study demonstrates that
in patients with mild - moderate obesity and type 2 diabetes, gastric bypass surgery leads to a sustained reduction
in weight, improvement
in glycemic control, and decrease
in cardiovascular risk compared to a medical diabetes and weight management program,» said lead author Donald C. Simonson, M.D., M.P.H., Sc.D., of the BWH Division of Endocrinology, Diabetes and
Hypertension.
Bhatt commented on the value of the study's cooperation between interventional and non-interventional blood pressure doctors, which demonstrated that a «good proportion» of
patients with resistant
hypertension in this study responded to expert medical therapy.
Renal denervation seems to be more successful at reducing blood pressure
in patients with resistant
hypertension when it includes accessory renal arteries, according to research recently presented at ESC Congress by Dr Linda Schmiedel from Germany.
Regorafenib had a similar safety and side effect profile to sorafenib,
with hypertension, hand - foot skin reaction, fatigue and diarrhea all being significantly more common
in patients taking the drug.
«Obesity - related illnesses, particularly obesity hypoventilation syndrome and sleep apnea, may play a role
in the development of pulmonary
hypertension, and so we examined whether the protective effects of obesity seen
in patients with heart failure were also seen
in these
patients,» said researcher Jose Caceres, MD, of Jacobi Medical Center / Albert Einstein College of Medicine
in the Bronx, NY.
This recommendation was based on the ability of screening to identify persons
with diabetes and evidence that more - intensive blood pressure treatment was associated
with reduced risk for cardiovascular events, including cardiovascular mortality,
in patients with diabetes and
hypertension.
«Higher BMI associated
with lower mortality risk
in patients with severe pulmonary
hypertension.»
«An obesity paradox may also occur
in patients with significant pulmonary
hypertension,» said lead author Dr. Ronald Zolty.
NAFLD is an increasingly common condition
in patients with obesity, type 2 diabetes, atherogenic dyslipidemia and arterial
hypertension.
This approach is a necessary prelude to detect differences
in the chronobiome to ultimately find therapeutic value
in patients with circadian time - dependent diseases, such as non-dipping
hypertension, nocturnal asthma, depression, and night - eating syndrome.
Finally, 32 percent of U.S.
patients with inadequately controlled
hypertension received a change or increase
in their medications compared to only 14 to 26 percent of those seen
in Europe.
Stratified reports could also raise awareness of racial disparities
in care, provide a framework for feedback and accountability of health plans and clinicians, and ideally promote effective efforts to improve care for
patients who experience worse outcomes, particularly black Americans
with diabetes,
hypertension, or heart disease.
Multipotent mesenchymal progenitor cells are present
in endarterectomized tissues from
patients with chronic thromboembolic pulmonary
hypertension.
A phase - 1 clinical trial of the drug
in human
patients with pulmonary
hypertension is expected to begin this winter.
These immune processes not only lead to scarring of the distal airways but also promote vascular artery narrowing
in some
patients, leading to an increased incidence of pulmonary artery
hypertension with age.
The deCODE study is the largest population genetic study ever carried out
in patients with essential
hypertension — high blood pressure without a known secondary cause — and reports the strongest genome - wide linkage of any research on this condition to date.
Our studies have shown that
patients with idiopathic pulmonary arterial
hypertension (IPAH, previously known as primary pulmonary
hypertension or PPH) have low levels of NO
in their exhaled breath that increase after initiation of vasodilator therapy.
Her recent research focus has been medication adherence
in older
patients with hypertension, adherence to physical activity recommendations
in patients with diabetes and provider adherence to medication guidelines.
Zachary T. Bloomgarden, MD, an endocrinologist at Mount Sinai School of Medicine
in New York City who specializes
in diabetes, prescribes these drugs to most of his
patients, particularly those
with hypertension, cardiovascular disease, or risk factors for heart disease, such as high cholesterol.
This article «
Patients with insulinoma show insulin resistance
in the absence of arterial
hypertension» answers that question.
In patients with essential hypertension, elevated ratios may also be a sign of primary aldosteronism (PA), for which recent reports suggest incidence may be as high as 10 - 15 % in hypertensive patient
In patients with essential
hypertension, elevated ratios may also be a sign of primary aldosteronism (PA), for which recent reports suggest incidence may be as high as 10 - 15 %
in hypertensive patient
in hypertensive
patients.
Coffee
with a high content of chlorogenic acids and low content of hydroxyhydroquinone improves postprandial endothelial dysfunction
in patients with borderline and stage 1
hypertension.
Here's the mercury levels
in hair samples from healthy people; here's the levels
in patients with diabetes or
hypertension.
Telangiectasias tend to be more numerous
in those
patients with other scleroderma related vascular disease (i.e., pulmonary arterial
hypertension).